Cargando…
Is There a Best First Line Biological/Small Molecule in IBD: Are We Ready for Sequencing?
Inflammatory bowel disease (IBD) is a chronic, life-long inflammatory condition of the gastrointestinal tract. Treatment strategy depends on the severity of the disease course. IBD physicians need to be aware of the life-long treatment options available. The goal is not only to achieve clinical remi...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026422/ https://www.ncbi.nlm.nih.gov/pubmed/35453498 http://dx.doi.org/10.3390/biomedicines10040749 |